Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM) - Contacts and Locations

Home

Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)

This study has been completed.

Study NCT00073255. Last updated on December 6, 2007. Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00073255

Locations


United States, New York
	Columbia University
	New York, New York, United States, 10032

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)